Caxton Associates (New York)’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Caxton Associates (New York)’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-8,871	Closed	-$590K	–	550
2020 Q2	$590K	Hold	8,871	–	–	0.05%	109
2020 Q1	$543K	Sell	8,871 -3,681	-29%	-$273K	0.1%	145
2019 Q4	$1.1M	Buy	12,552 +3,687	+42%	+$311K	0.15%	79
2019 Q3	$669K	Buy	8,865 +6,169	+229%	+$501K	0.13%	89
2019 Q2	$230K	Hold	2,696	–	–	0.03%	343
2019 Q1	$291K	Buy	+2,696	New	+$268K	0.04%	259

Other funds holding TARO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Caxton Associates (New York)'s TARO Position: Q3 2020 in Review

Caxton Associates (New York) sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2020, closing a stake of 8,871 shares — an estimated $590K sold.

Caxton Associates (New York) first reported a position in TARO in Q1 2019 and held it in 6 quarters. The position peaked at $1.1M in Q4 2019. 78 funds tracked by Wall St. Rank hold TARO as of Q3 2020.

Caxton Associates (New York) reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2020 after selling out during the quarter.
Caxton Associates (New York) sold 8,871 Taro Pharmaceutical Industries Ltd. shares in Q3 2020, an estimated $590K.
Caxton Associates (New York) first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2019 and held it in 6 quarters.
Caxton Associates (New York)'s Taro Pharmaceutical Industries Ltd. position peaked at $1.1M in Q4 2019.
78 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2020.

Based on Caxton Associates (New York)'s 13F filing for Q3 2020, filed 16 Nov 2020.